Filing Flows › 8-K events › Atlantic American
Atlantic American: notice of delisting or failure to meet a listing standard
Form 8-K filed Oct 22, 2026 · items 3.01
Delisting noticesAtlantic American Corporation Receives Expected Nasdaq Staff Delisting Determination Related to Delayed Filing of Periodic Reports
What the filing says
On October 16, 2026, Atlantic American Corporation (the “Company”) received a Staff Delisting Determination (the “Staff Determination”) from the listing qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that Nasdaq has initiated a process to delist the Company’s common stock as a resu
Read the filing on SEC EDGAR →
What usually followsAcross 492 8-Ks reporting Item 3.01 (delisting notice or listing-rule failure) in our universe, the stock's median move the next session was 0.0% (typical size ±2.1%, up 46% of the time); over the following 21 sessions, −0.2%. Every item ranked →
What this kind of filing means
Item 3.01 — Notice of delisting or failure to meet a listing standard. A delisting notice starts a compliance window; companies often answer with a reverse split, a plan, or a move to another market.
Atlantic American at a glance
Atlantic American, Q4 2025: revenue $51.3M (+5% year over year), operating margin 3.3%. The chart follows the revenue to costs, profit and cash.
Atlantic American: every quarter, Q/Q and Y/Y, holders and guidance →
Other recent delisting notices
- Barfresh Food Group Nov 6, 2026
- Fifth Era Acquisition Corp I Nov 6, 2026
- Tempest Therapeutics Nov 6, 2026
- Roku Nov 6, 2026
- Bowman Consulting Group Nov 6, 2026
- Knightscope Nov 6, 2026
- Curis Nov 6, 2026
- Intrusion Nov 5, 2026
- Karyopharm Therapeutics Nov 5, 2026
- Cognition Therapeutics Nov 5, 2026
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.